Ngā hua rapu - Manrose Singh

  • E whakaatu ana i te 1 - 4 hua o te 4
Whakamahine hua
  1. 1
    Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights

    Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights mā Ashwin Ragupathi, Manrose Singh, Alexis M. Perez, Dong Zhang

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments

    The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments mā Noelle J. Batista, Sanket G. Desai, Alexis M. Perez, Alexa Finkelstein, Rachel Radigan, Manrose Singh, Aaron Landman, Brian Drittel, Daniella Abramov, Mina Ahsan, Samantha Cornwell, Dong Zhang

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

    SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors mā Leila Dardaei, Hui Qin Wang, Manrose Singh, Paul Fordjour, Katherine X Shaw, Satoshi Yoda, Gráinne Kerr, Kristine Yu, Jinsheng Liang, Yichen Cao, Yan Chen, Michael S. Lawrence, Adam Langenbucher, Justin F. Gainor, Luc Friboulet, Ibiayi Dagogo‐Jack, David T. Myers, Emma Labrot, David A. Ruddy, Melissa Parks, Dana Lee, Richard H. DiCecca, Susan E. Moody, Huai-Xiang Hao, Morvarid Mohseni, Matthew J. LaMarche, Juliet Williams, Keith Hoffmaster, Giordano Caponigro, Alice T. Shaw, Aaron N. Hata, Cyril H. Benes, Fang Li, Jeffrey A. Engelman

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in<i>ALK</i>-Rearranged Lung Cancer

    Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in<i>ALK</i>-Rearranged Lung Cancer mā Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino‐Kenudson, Jeffrey A. Engelman, Alice T. Shaw

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: